Inflammatory and injury signals released from the post-stenotic human kidney

European Heart Journal

Volumn 34, Issue 7, 2013, Pages 540-548

  Eirin, Alfonso ^a   Gloviczki, Monika L ^a   Tang, Hui ^a   Gössl, Mario ^a   Jordan, Kyra L ^a   Woollard, John R ^a   Lerman, Amir ^a   Grande, Joseph P ^a   Textor, Stephen C ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cytokines; Inflammatory biomarkers; Progenitor cells; Renal artery stenosis; Renovascular hypertension

Indexed keywords

ANGIOGENIC FACTOR; CD34 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL HOMING; CELL LEVEL; CELL REGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFERIOR CAVA VEIN; INFLAMMATION; KIDNEY; KIDNEY ARTERY STENOSIS; KIDNEY INJURY; KIDNEY VEIN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RENOVASCULAR HYPERTENSION; STEM CELL;

ACUTE KIDNEY INJURY; AGED; ANTIGENS, CD34; ARTERITIS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CYTOKINES; E-SELECTIN; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL ARTERY OBSTRUCTION; RENAL VEINS; STEM CELL FACTOR; STEM CELLS; VASCULAR CELL ADHESION MOLECULE-1; VENA CAVA, INFERIOR;

EID: 84874239407     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs197     Document Type: Article

References (40)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-1252.
2. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002;36:443-451.
3. Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC, Ishani A, Collins AJ, Foley RN. Atherosclerotic renovascular disease in united states patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005;68: 293-301.
4. Losito A, Fagugli RM, Zampi I, Parente B, de Rango P, Giordano G, Cao P. Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens 1996;9:1062-1067.
5. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone ML, Tacconelli S, Palatresi S, Bencini C, Del Vecchio C, Mansueto G, Arosio E, Santonastaso CL, Lechi A, Morganti A, Patrono C. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 2002;106:2800-2805.
6. Nobuhiko A, Suganuma E, Babaev VR, Fogo A, Swift LL, Linton MF, Fazio S, Ichikawa I, Kon V. Angiotensin ii amplifies macrophage-driven atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:2143-2148.
7. Stouffer GA, Pathak A, Rojas M. Unilateral renal artery stenosis causes a chronic vascular inflammatory response in apoe2/2 mice. Trans Am Clin Climatol Assoc 2010;121:252-264; 264-256.
8. Zhu XY, Chade AR, Krier JD, Daghini E, Lavi R, Guglielmotti A, Lerman A, Lerman LO. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 2009;27: 2063-2073.
9. Matavelli LC, Huang J, Siragy HM. Angiotensin at receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 2011;57: 308-313.
10. Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ, Tsai MY, Cruickshanks KJ, Schubert CR, Brazy PC, Coresh J, Klein R. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 2011;80:1231-1238.
11. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med 2005;56:79-101.
12. Chade AR, Zhu XY, Krier JD, Jordan KL, Textor SC, Grande JP, Lerman A, Lerman LO. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 2010;28:1039-1047.
13. Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, Textor SC. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 2010;55: 961-966.
14. Murphy TP, Cooper CJ, Dworkin LD, Henrich WL, Rundback JH, Matsumoto AH, Jamerson KA, D'Agostino RB. The cardiovascular outcomes with renal atherosclerotic lesions (coral) study: rationale and methods. J Vasc Interv Radiol 2005; 16:1295-1300.
15. Gossl M, Modder UI, Gulati R, Rihal CS, Prasad A, Loeffler D, Lerman LO, Khosla S, Lerman A. Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J 2010;31:2909-2914.
16. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008;197:496-503.
17. Boilson BA, Kiernan TJ, Harbuzariu A, Nelson RE, Lerman A, Simari RD. Circulating cd34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med 2008;5:489-496.
18. Kiernan TJ, Boilson BA, Tesmer L, Harbuzariu A, Simari RD, Barsness GW. Effect of enhanced external counterpulsation on circulating cd34+ progenitor cell subsets. Int J Cardiol 2011;153:202-206.
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
20. Conlon PJ, O'Riordan E, Kalra PA. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kidney Dis 2000;35: 573-587.
21. Johns EJ. Inflammation: the underlying foe in renovascular hypertension? J Hypertens 2009;27:1964-1965.
22. Chade AR, Zhu X, Mushin OP, Napoli C, Lerman A, Lerman LO. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J 2006;20:1706-1708.
23. Chade AR, Rodriguez-Porcel M, Herrmann J, Zhu X, Grande JP, Napoli C, Lerman A, Lerman LO. Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 2004;15:958-966.
24. Eng E, Veniant M, Floege J, Fingerle J, Alpers CE, Menard J, Clozel JP, Johnson RJ. Renal proliferative and phenotypic changes in rats with two-kidney, one-clip goldblatt hypertension. Am J Hypertens 1994;7:177-185.
25. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JF, Dammrich J, Luft FC. Early interstitial changes in hypertension-induced renal injury. Hypertension 1993;22: 754-765.
26. Cheng J, Zhou W, Warner GM, Knudsen BE, Garovic VD, Gray CE, Lerman LO, Platt JL, Romero JC, Textor SC, Nath KA, Grande JP. Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 2009;297:F1055-F1068.
27. Wright JR, Duggal A, Thomas R, Reeve R, Roberts IS, Kalra PA. Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant 2001;16:765-770.
28. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-512.
29. Ernandez T, Mayadas TN. Immunoregulatory role of tnfalpha in inflammatory kidney diseases. Kidney Int. 2009;76:262-276.
30. Alhadad A, Guron G, Fortuna-Nowakowska E, Saeed A, Mattiasson I, Jensen G, Lindblad B, Gottsater A, Herlitz H. Renal angioplasty causes a rapid transient increase in inflammatory biomarkers, but reduced levels of interleukin-6 and endothelin-1 1 month after intervention. J Hypertens 2007;25:1907-1914.
31. Zhu XY, Daghini E, Chade AR, Napoli C, Ritman EL, Lerman A, Lerman LO. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J Am Soc Nephrol 2007;18:1209-1217.
32. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
33. Wang Y, Harris DC. Macrophages in renal disease. J Am Soc Nephrol 2011;22: 21-27.
34. George S, Ruan XZ, Navarrete C, Turner D, Reynard M, Sweny P, Hamilton G, Wheeler DC, Powis SH, Moorhead JF, Varghese Z. Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 2004;63:470-475.
35. Krishnamurthy P, Thal M, Verma S, Hoxha E, Lambers E, Ramirez V, Qin G, Losordo D, Kishore R. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res 2011;109:1280-1289.
36. Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovectormediated elevation of serum levels of sdf-1, vegf, and angiopoietin-1. Ann N Y Acad Sci 2001;938:36-45; discussion 45-37.
37. Favreau F, Zhu XY, Krier JD, Lin J, Warner L, Textor SC, Lerman LO. Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure. Kidney Int 2010;78:1110-1118.
38. Tullis MJ, Zierler RE, Caps MT, Bergelin RO, Cantwell-Gab K, Strandness DE Jr. Clinical evidence of contralateral renal parenchymal injury in patients with unilateral atherosclerotic renal artery stenosis. Ann Vasc Surg 1998;12: 122-127.
39. Gobe GC, Axelsen RA, Searle JW. Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest 1990;63:770-779.
40. Trani C, Porto I, Tommasino A, Giammarinaro M, Burzotta F, Niccoli G, Leone AM, Coroleu SF, Cautilli G, Mazzari MA, Schiavoni G, Crea F. Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: a prospective study. Int J Cardiol 2012; Advance Access published April 12, 2012, doi:10.1016/j.ijcard.2012.03.078.